By Akshay Kumar, Partner & Andrea Bernardini, Analyst Email: [email protected] [email protected] Bulgaria introduced multiple reforms to their healthcare system since 2011. This included the introduction of
By Ciaran Cassidy, Snr Analyst Email: [email protected] With one of the fastest-growing economies and the second largest population in the world India is a market
By Jens Leutloff, Senior Consultant Email: [email protected] Partners4Access asked payer experts from France, Germany, Italy, Spain, and the Nordics what the key trends are for
By Chloe Sheppard, Analyst Email: [email protected] The issue of affordability and access to medicines has been brought to the forefront of policymakers’ and payers’ attention
Trump finally signs executive order on Medicare drug pricing but will anything change on the ground?
By Max Rex, Consultant Email: [email protected] After years of rhetoric about drug pricing, President Trump signed an executive order on Sunday 13th September which aims
By Ciaran Cassidy, S Analyst Email: [email protected] At the World Orphan Drug Conference (WODC) this year Dr Maryam Matar presented on the success of the
By Chloe Sheppard, Analyst Email: [email protected] The European Commission is imminently expected to publish a report evaluating the pros and cons of the EU Orphan